Literature DB >> 16601367

The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients.

M S Al-Moundhri1, B Al-Bahrani, I A Burney, V Nirmala, A Al-Madhani, K Al-Mawaly, M Al-Nabhani, V Thomas, S S Ganguly, C S Grant.   

Abstract

BACKGROUND: Gastric cancer is the most common cancer in Oman and a leading cause of cancer death. The variation in survival rates between countries and ethnic groups has been attributed to early detection policies, differences in clinicopathological features, treatment approaches, and biological characteristics. There were no previous reports on gastric cancer from Oman and very few studies on Asian Arabs. AIM: To evaluate the impact of clinicopathological and treatment variables on the survival prospects of Omani Arab patients diagnosed with gastric cancer.
METHODS: The medical records of 339 Omani Arab patients diagnosed with invasive gastric adenocarcinoma during the period 1993-2004 were retrospectively reviewed. The relative importance of clinicopathological features and surgical and medical treatments were assessed using univariate and multivariate analyses.
RESULTS: Most patients had distal ulcerating-type gastric cancer and presented at advanced stages. The median survival time for the entire cohort was 12 months (95% CI 9.7-14.4) with a 5-year overall survival rate of 16.7%. On univariate analysis of 237 patients who underwent surgical resection, the following positive prognostic factors emerged as significant: early overall TNM stage, early T stage, negative lymph nodes, tumor size <5 cm, ulcerating macroscopic appearance, and curative surgical attempt. The independent prognostic factors on multivariate analysis were T stage and lymph node involvement.
CONCLUSION: The overall T and N stages are the most important determining factor for survival in Omani Arab patients. More efforts need to be made for the early detection of gastric cancer in developing countries such as Oman, while continuing to employ the standard surgical and medical treatments.

Entities:  

Mesh:

Year:  2006        PMID: 16601367     DOI: 10.1159/000092584

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

1.  Outcome as a measure of quality of care in oncology: experience at sultan qaboos university hospital, oman.

Authors:  Ikram A Burney; Mansour S Al Moundhri; Azhar J Rizvi; Shyam S Ganguly; Rashid Al Abri; Rafi A Ashrafi
Journal:  Sultan Qaboos Univ Med J       Date:  2008-03

2.  Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases.

Authors:  Theresa L A Jeuck; Christian Wittekind
Journal:  Gastric Cancer       Date:  2014-02-19       Impact factor: 7.370

3.  Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.

Authors:  Mansour-S Al-Moundhri; A Al-Shukaili; M Al-Nabhani; B Al-Bahrani; I-A Burney; A Rizivi; S-S Ganguly
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

4.  Effect of lymph node micrometastases on prognosis of gastric carcinoma.

Authors:  Ze-Yu Wu; Jing-Hua Li; Wen-Hua Zhan; Yu-Long He; Jin Wan
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

Review 5.  Current status and scope of lymph node micrometastasis in gastric cancer.

Authors:  Chang Min Lee; Sung-Soo Park; Jong-Han Kim
Journal:  J Gastric Cancer       Date:  2015-03-31       Impact factor: 3.720

6.  BRCA1/BRCA2 mutation spectrum analysis in South Asia: a systematic review.

Authors:  Sanjeev Kharel; Suraj Shrestha; Siddhartha Yadav; Prafulla Shakya; Sujita Baidya; Suzita Hirachan
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.